• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

    5/6/22 10:02:00 AM ET
    $AMRN
    $ARDX
    $BAND
    $BANF
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AMRN alert in real time by email

    Upgrades

    For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

    According to Guggenheim, the prior rating for NextGen Healthcare Inc (NASDAQ:NXGN) was changed from Neutral to Buy. In the third quarter, NextGen Healthcare showed an EPS of $0.24, compared to $0.26 from the year-ago quarter. The stock has a 52-week-high of $21.87 and a 52-week-low of $13.64. At the end of the last trading period, NextGen Healthcare closed at $19.52.

    According to CLSA, the prior rating for Melco Resorts and Entertainment Ltd (NASDAQ:MLCO) was changed from Outperform to Buy. For the first quarter, Melco Resorts and Enter had an EPS of $0.37, compared to year-ago quarter EPS of $0.44. The stock has a 52-week-high of $19.18 and a 52-week-low of $5.12. At the end of the last trading period, Melco Resorts and Enter closed at $5.19.

    Raymond James upgraded the previous rating for Jounce Therapeutics Inc (NASDAQ:JNCE) from Outperform to Strong Buy. Jounce Therapeutics earned $0.72 in the first quarter, compared to $0.58 in the year-ago quarter. The current stock performance of Jounce Therapeutics shows a 52-week-high of $9.81 and a 52-week-low of $4.79. Moreover, at the end of the last trading period, the closing price was at $4.86.

    B of A Securities upgraded the previous rating for EPAM Systems Inc (NYSE:EPAM) from Neutral to Buy. For the first quarter, EPAM Sys had an EPS of $2.49, compared to year-ago quarter EPS of $1.81. At the moment, the stock has a 52-week-high of $725.40 and a 52-week-low of $168.59. EPAM Sys closed at $346.00 at the end of the last trading period.

    DZ Bank upgraded the previous rating for Stellantis NV (NYSE:STLA) from Hold to Buy. NoneAt the moment, the stock has a 52-week-high of $21.99 and a 52-week-low of $13.06. Stellantis closed at $13.42 at the end of the last trading period.

    For Hersha Hospitality Trust (NYSE:HT), Stifel upgraded the previous rating of Hold to Buy. In the first quarter, Hersha Hospitality showed an EPS of $0.06, compared to $0.36 from the year-ago quarter. At the moment, the stock has a 52-week-high of $12.42 and a 52-week-low of $7.92. Hersha Hospitality closed at $9.96 at the end of the last trading period.

    For Pactiv Evergreen Inc (NASDAQ:PTVE), RBC Capital upgraded the previous rating of Sector Perform to Outperform. Pactiv Evergreen earned $0.24 in the first quarter, compared to $0.01 in the year-ago quarter. At the moment, the stock has a 52-week-high of $16.49 and a 52-week-low of $8.71. Pactiv Evergreen closed at $10.23 at the end of the last trading period.

    For TPI Composites Inc (NASDAQ:TPIC), Roth Capital upgraded the previous rating of Neutral to Buy. For the first quarter, TPI Composites had an EPS of $0.71, compared to year-ago quarter EPS of $0.05. The current stock performance of TPI Composites shows a 52-week-high of $52.18 and a 52-week-low of $9.23. Moreover, at the end of the last trading period, the closing price was at $12.36.

    Piper Sandler upgraded the previous rating for Boot Barn Holdings Inc (NYSE:BOOT) from Neutral to Overweight. Boot Barn Holdings earned $2.23 in the third quarter, compared to $0.99 in the year-ago quarter. The current stock performance of Boot Barn Holdings shows a 52-week-high of $134.50 and a 52-week-low of $66.58. Moreover, at the end of the last trading period, the closing price was at $95.77.

    See all analyst ratings upgrades.

    Downgrades

    According to Needham, the prior rating for Bandwidth Inc (NASDAQ:BAND) was changed from Buy to Hold. In the first quarter, Bandwidth showed an EPS of $0.09, compared to $0.30 from the year-ago quarter. The stock has a 52-week-high of $145.97 and a 52-week-low of $22.00. At the end of the last trading period, Bandwidth closed at $26.74.

    For Northwest Bancshares Inc (NASDAQ:NWBI), Piper Sandler downgraded the previous rating of Neutral to Underweight. In the first quarter, Northwest Bancshares showed an EPS of $0.22, compared to $0.32 from the year-ago quarter. The current stock performance of Northwest Bancshares shows a 52-week-high of $15.14 and a 52-week-low of $12.33. Moreover, at the end of the last trading period, the closing price was at $12.65.

    For BancFirst Corp (NASDAQ:BANF), Piper Sandler downgraded the previous rating of Neutral to Underweight. For the first quarter, BancFirst had an EPS of $1.08, compared to year-ago quarter EPS of $1.27. The stock has a 52-week-high of $86.82 and a 52-week-low of $53.77. At the end of the last trading period, BancFirst closed at $84.67.

    For Lancaster Colony Corp (NASDAQ:LANC), Benchmark downgraded the previous rating of Buy to Hold. Lancaster Colony earned $0.71 in the third quarter, compared to $1.05 in the year-ago quarter. The stock has a 52-week-high of $201.31 and a 52-week-low of $135.82. At the end of the last trading period, Lancaster Colony closed at $139.46.

    For Silicon Motion Technology Corp (NASDAQ:SIMO), Needham downgraded the previous rating of Buy to Hold. For the first quarter, Silicon Motion Technology had an EPS of $1.72, compared to year-ago quarter EPS of $1.11. The current stock performance of Silicon Motion Technology shows a 52-week-high of $98.65 and a 52-week-low of $58.86. Moreover, at the end of the last trading period, the closing price was at $95.16.

    According to Canaccord Genuity, the prior rating for Virgin Galactic Holdings Inc (NYSE:SPCE) was changed from Buy to Hold. In the first quarter, Virgin Galactic Hldgs showed an EPS of $0.36, compared to $0.55 from the year-ago quarter. The stock has a 52-week-high of $57.51 and a 52-week-low of $6.70. At the end of the last trading period, Virgin Galactic Hldgs closed at $7.50.

    For iRobot Corp (NASDAQ:IRBT), JP Morgan downgraded the previous rating of Neutral to Underweight. For the first quarter, iRobot had an EPS of $0.66, compared to year-ago quarter EPS of $0.41. At the moment, the stock has a 52-week-high of $106.65 and a 52-week-low of $48.36. iRobot closed at $53.09 at the end of the last trading period.

    According to Mizuho, the prior rating for Black Hills Corp (NYSE:BKH) was changed from Buy to Neutral. Black Hills earned $1.82 in the first quarter, compared to $1.54 in the year-ago quarter. At the moment, the stock has a 52-week-high of $80.95 and a 52-week-low of $61.95. Black Hills closed at $75.34 at the end of the last trading period.

    For Ardelyx Inc (NASDAQ:ARDX), Cantor Fitzgerald downgraded the previous rating of Overweight to Neutral. For the first quarter, Ardelyx had an EPS of $0.21, compared to year-ago quarter EPS of $0.34. The stock has a 52-week-high of $8.25 and a 52-week-low of $0.58. At the end of the last trading period, Ardelyx closed at $0.84.

    According to Roth Capital, the prior rating for FuboTV Inc (NYSE:FUBO) was changed from Buy to Neutral. FuboTV earned $0.69 in the first quarter, compared to $0.55 in the year-ago quarter. The current stock performance of FuboTV shows a 52-week-high of $35.10 and a 52-week-low of $3.68. Moreover, at the end of the last trading period, the closing price was at $4.12.

    For Vapotherm Inc (NYSE:VAPO), Canaccord Genuity downgraded the previous rating of Buy to Hold. In the first quarter, Vapotherm showed an EPS of $0.83, compared to $0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $31.87 and a 52-week-low of $3.93. Vapotherm closed at $4.48 at the end of the last trading period.

    Piper Sandler downgraded the previous rating for Wayfair Inc (NYSE:W) from Overweight to Neutral. In the first quarter, Wayfair showed an EPS of $1.96, compared to $1.00 from the year-ago quarter. The stock has a 52-week-high of $339.56 and a 52-week-low of $65.32. At the end of the last trading period, Wayfair closed at $67.45.

    For Vimeo Inc (NASDAQ:VMEO), Piper Sandler downgraded the previous rating of Overweight to Neutral. The stock has a 52-week-high of $58.00 and a 52-week-low of $9.15. At the end of the last trading period, Vimeo closed at $10.37.

    According to Stifel, the prior rating for Hanesbrands Inc (NYSE:HBI) was changed from Buy to Hold. In the first quarter, Hanesbrands showed an EPS of $0.34, compared to $0.39 from the year-ago quarter. The current stock performance of Hanesbrands shows a 52-week-high of $22.82 and a 52-week-low of $12.70. Moreover, at the end of the last trading period, the closing price was at $12.71.

    For Ball Corp (NYSE:BLL), RBC Capital downgraded the previous rating of Outperform to Sector Perform. Ball earned $0.77 in the first quarter, compared to $0.72 in the year-ago quarter. The current stock performance of Ball shows a 52-week-high of $98.09 and a 52-week-low of $74.13. Moreover, at the end of the last trading period, the closing price was at $76.80.

    According to Cantor Fitzgerald, the prior rating for TherapeuticsMD Inc (NASDAQ:TXMD) was changed from Overweight to Neutral. TherapeuticsMD earned $0.09 in the fourth quarter, compared to $0.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $1.39 and a 52-week-low of $0.17. TherapeuticsMD closed at $0.17 at the end of the last trading period.

    Cantor Fitzgerald downgraded the previous rating for Entasis Therapeutics Holdings Inc (NASDAQ:ETTX) from Overweight to Neutral. Entasis Therapeutics Hldg earned $0.32 in the first quarter, compared to $0.29 in the year-ago quarter. The stock has a 52-week-high of $3.88 and a 52-week-low of $1.40. At the end of the last trading period, Entasis Therapeutics Hldg closed at $1.89.

    According to JP Morgan, the prior rating for Amarin Corp PLC (NASDAQ:AMRN) was changed from Neutral to Underweight. In the first quarter, Amarin Corp showed an EPS of $0.06, compared to $0.00 from the year-ago quarter. The stock has a 52-week-high of $5.97 and a 52-week-low of $1.34. At the end of the last trading period, Amarin Corp closed at $1.35.

    JP Morgan downgraded the previous rating for Corteva Inc (NYSE:CTVA) from Overweight to Neutral. Corteva earned $0.97 in the first quarter, compared to $0.79 in the year-ago quarter. The current stock performance of Corteva shows a 52-week-high of $62.04 and a 52-week-low of $40.60. Moreover, at the end of the last trading period, the closing price was at $58.04.

    According to JP Morgan, the prior rating for FuboTV Inc (NYSE:FUBO) was changed from Neutral to Underweight. For the first quarter, FuboTV had an EPS of $0.69, compared to year-ago quarter EPS of $0.55. The current stock performance of FuboTV shows a 52-week-high of $35.10 and a 52-week-low of $3.68. Moreover, at the end of the last trading period, the closing price was at $4.12.

    See all analyst ratings downgrades.

    Initiations

    Ladenburg Thalmann initiated coverage on Quoin Pharmaceuticals Ltd (NASDAQ:QNRX) with a Buy rating. The price target for Quoin Pharmaceuticals is set to $2.00. For the third quarter, Quoin Pharmaceuticals had an EPS of $1.40, compared to year-ago quarter EPS of $0.00. The current stock performance of Quoin Pharmaceuticals shows a 52-week-high of $29.80 and a 52-week-low of $0.78. Moreover, at the end of the last trading period, the closing price was at $0.81.

    CICC initiated coverage on FinVolution Group (NYSE:FINV) with an Outperform rating. The price target for FinVolution Gr is set to $5.63. FinVolution Gr earned $0.37 in the fourth quarter, compared to $0.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of $10.41 and a 52-week-low of $2.68. FinVolution Gr closed at $3.80 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $AMRN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMRN
    $ARDX
    $BAND
    $BANF

    CompanyDatePrice TargetRatingAnalyst
    Corteva Inc.
    $CTVA
    2/9/2026$80.00Buy → Neutral
    UBS
    Stellantis N.V.
    $STLA
    2/9/2026Underperform → Peer Perform
    Wolfe Research
    Boot Barn Holdings Inc.
    $BOOT
    2/6/2026$237.00Equal-Weight → Overweight
    Stephens
    Coupang Inc.
    $CPNG
    2/5/2026$17.00Underperform
    Bernstein
    Corteva Inc.
    $CTVA
    2/5/2026$77.00Overweight → Neutral
    Analyst
    FuboTV Inc.
    $FUBO
    2/5/2026$3.00Neutral → Buy
    Seaport Research Partners
    Stellantis N.V.
    $STLA
    2/3/2026$10.90Overweight → Equal-Weight
    Morgan Stanley
    Bandwidth Inc.
    $BAND
    1/23/2026$20.00Buy
    B. Riley Securities
    More analyst ratings

    $AMRN
    $ARDX
    $BAND
    $BANF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Campana Robert M bought $25,248 worth of Northwest Bancshares (2,000 units at $12.62), increasing direct ownership by 3% to 67,366 units (SEC Form 4)

    4 - Northwest Bancshares, Inc. (0001471265) (Issuer)

    1/29/26 4:27:58 PM ET
    $NWBI
    Major Banks
    Finance

    Director Thompson Tommy G bought $14,031 worth of shares (8,400 units at $1.67), increasing direct ownership by 57% to 23,179 units (SEC Form 4)

    4 - TherapeuticsMD, Inc. (0000025743) (Issuer)

    12/29/25 4:23:31 PM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Tullio David M bought $18,398 worth of Northwest Bancshares (1,500 units at $12.27), increasing direct ownership by 5% to 30,051 units (SEC Form 4)

    4 - Northwest Bancshares, Inc. (0001471265) (Issuer)

    12/9/25 3:50:10 PM ET
    $NWBI
    Major Banks
    Finance

    $AMRN
    $ARDX
    $BAND
    $BANF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Corteva downgraded by UBS with a new price target

    UBS downgraded Corteva from Buy to Neutral and set a new price target of $80.00

    2/9/26 6:59:50 AM ET
    $CTVA
    Farming/Seeds/Milling
    Consumer Staples

    Stellantis upgraded by Wolfe Research

    Wolfe Research upgraded Stellantis from Underperform to Peer Perform

    2/9/26 6:58:53 AM ET
    $STLA
    Auto Manufacturing
    Industrials

    Boot Barn Holdings upgraded by Stephens with a new price target

    Stephens upgraded Boot Barn Holdings from Equal-Weight to Overweight and set a new price target of $237.00

    2/6/26 7:53:34 AM ET
    $BOOT
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $AMRN
    $ARDX
    $BAND
    $BANF
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated

    10/20/23 4:37:52 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:43:04 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZA™ issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZA™ (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:37:08 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMRN
    $ARDX
    $BAND
    $BANF
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Quoin Pharmaceuticals Ltd.

    SCHEDULE 13G/A - Quoin Pharmaceuticals, Ltd. (0001671502) (Subject)

    2/11/26 5:10:41 PM ET
    $QNRX
    Medical/Dental Instruments
    Health Care

    SEC Form 10-K filed by Black Hills Corporation

    10-K - BLACK HILLS CORP /SD/ (0001130464) (Filer)

    2/11/26 12:58:57 PM ET
    $BKH
    Electric Utilities: Central
    Utilities

    SEC Form EFFECT filed by Black Hills Corporation

    EFFECT - BLACK HILLS CORP /SD/ (0001130464) (Filer)

    2/9/26 12:15:27 AM ET
    $BKH
    Electric Utilities: Central
    Utilities

    $AMRN
    $ARDX
    $BAND
    $BANF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Melco attains world's most Forbes Travel Guide Five-Star Awards in 2026 for any integrated resort operator

    MACAU, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment proudly announces it has achieved historic leadership position in the newly published 2026 Forbes Travel Guide (FTG) by garnering 19 Five-Star Awards, topping the competition as the world's integrated resort operator with the most FTG Five-Star Awards and reinforcing its position as the region's premier luxury hospitality provider. The achievement is anchored by the attainment of 107 FTG Stars across the Company's Hotel, Restaurant and Spa categories for properties including City of Dreams, Studio City, Altira Macau, and City of Dreams Manila. Mr. Lawrence Ho, Chairman & CEO, Melco, said, "We are deeply honored to have

    2/11/26 11:45:01 PM ET
    $MLCO
    Hotels/Resorts
    Consumer Discretionary

    Abrams Capital, Durable Capital Partners, and Foxhaven Join Greenoaks and Altimeter in Legal Effort to End Korea's Discrimination Against U.S. Companies and Uphold U.S.-Korea Trade Commitments

    Leading investors join Greenoaks and Altimeter in filing a notice of intent to arbitrate under KORUS and submit letters in support of the previously-filed USTR petition Mounting investor support echoes U.S. Government demands and trade warnings to Korea Abrams Capital, Durable Capital Partners, and Foxhaven have joined Greenoaks and Altimeter's (together, the "U.S. Investors") legal challenge against the Government of the Republic of Korea (the "ROK Government") to stop Korea's discriminatory treatment against Coupang, Inc. (NYSE:CPNG) and other U.S. companies. As previously announced, Greenoaks and Altimeter formally notified the ROK Government of their intent to file arbitration cla

    2/11/26 9:45:00 AM ET
    $CPNG
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026

    DUBLIN and BRIDGEWATER, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular care, today announced that it will report fourth quarter and full year 2025 financial results and conduct a conference call on Wednesday, February 25, 2026. The Company will issue a press release detailing its fourth quarter and full year 2025 financial results in the pre-market hours, followed by a conference call with senior management at 8:00 a.m. ET. Information on how to participate is as follows. Access to the live call:Via telephone: Dial in within the United States: 888-506-0062International dial in: 973-528-0011Acces

    2/11/26 8:00:00 AM ET
    $AMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMRN
    $ARDX
    $BAND
    $BANF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Vice President Foraker Randy exercised 3,000 shares at a strike of $20.83 and sold $359,735 worth of shares (3,000 units at $119.91) (SEC Form 4)

    4 - BANCFIRST CORP /OK/ (0000760498) (Issuer)

    2/11/26 10:30:58 AM ET
    $BANF
    Major Banks
    Finance

    President and CEO Evans Linden R was granted 17,793 shares and covered exercise/tax liability with 4,085 shares, increasing direct ownership by 10% to 170,986 units (SEC Form 4)

    4 - BLACK HILLS CORP /SD/ (0001130464) (Issuer)

    2/10/26 9:45:06 PM ET
    $BKH
    Electric Utilities: Central
    Utilities

    SVP - Utilities Jones Marne M was granted 4,106 shares and covered exercise/tax liability with 1,798 shares, increasing direct ownership by 6% to 38,167 units (SEC Form 4)

    4 - BLACK HILLS CORP /SD/ (0001130464) (Issuer)

    2/10/26 9:32:20 PM ET
    $BKH
    Electric Utilities: Central
    Utilities

    $AMRN
    $ARDX
    $BAND
    $BANF
    Leadership Updates

    Live Leadership Updates

    View All

    EPAM to Host Investor Day on March 12, 2026

    Sharing Long-Term Growth Strategy for the Next Wave of AI-Driven Business Transformation NEWTOWN, Pa., Jan. 13, 2026 /PRNewswire/ -- EPAM Systems, Inc. (NYSE: EPAM), a leading digital and AI transformation company, will host an Investor Day in Boston on March 12, 2026. The event will feature remarks by EPAM's Chief Executive Officer and President, Balazs Fejes, and Chief Financial Officer, Jason Peterson, as well as other members of the executive leadership team. "Our Investor Day is an opportunity to demonstrate the solid progress we've made against our long-term strategic pr

    1/13/26 8:02:00 AM ET
    $EPAM
    EDP Services
    Technology

    Sandisk Set to Join S&P 500; Upwork, First Interstate BancSystem, PTC Therapeutics to Join S&P SmallCap 600

    NEW YORK, Nov. 24, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P SmallCap 600:  S&P SmallCap 600 constituent Sandisk Corp. (NASD: SNDK) will replace The Interpublic Group of Companies Inc. (NYSE:IPG) in the S&P 500, and PTC Therapeutics Inc. (NASD: PTCT) will replace Sandisk in the S&P SmallCap 600 effective prior to the opening of trading on Friday, November 28. S&P 500 constituent Omnicom Group Inc. (NYSE:OMC) is acquiring The Interpublic Group of Companies in a deal expected to close soon, pending final conditions.Upwork Inc. (NASD: UPWK) will replace Premier Inc. (NASD: PINC) in the S&P SmallCap 600 effective prior to the open of trading

    11/24/25 6:01:00 PM ET
    $FIBK
    $GIL
    $HBI
    Major Banks
    Finance
    Apparel
    Consumer Discretionary

    Wayfair Appoints Retail Industry Leader Hal Lawton to Board of Directors

    BOSTON, Nov. 7, 2025 /PRNewswire/ -- Wayfair Inc. (NYSE:W), the destination for all things home, today announced the appointment of Hal Lawton, president and CEO of Tractor Supply Company, to its board of directors, effective as of November 6, 2025. "Hal brings extensive leadership experience and a remarkable record of success in the retail industry, and we are excited to welcome him to our board," said Niraj Shah, co-founder, co-chairman and CEO of Wayfair. "His perspective will be invaluable as we continue to scale and strengthen our business." Lawton has served as CEO of Tr

    11/7/25 7:00:00 AM ET
    $W
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMRN
    $ARDX
    $BAND
    $BANF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Pactiv Evergreen Inc.

    SC 13D/A - Pactiv Evergreen Inc. (0001527508) (Subject)

    12/9/24 10:47:22 AM ET
    $PTVE
    Containers/Packaging
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by TPI Composites Inc.

    SC 13G/A - TPI COMPOSITES, INC (0001455684) (Subject)

    11/14/24 7:49:51 PM ET
    $TPIC
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by Quoin Pharmaceuticals Ltd.

    SC 13G/A - Quoin Pharmaceuticals, Ltd. (0001671502) (Subject)

    11/14/24 7:23:29 PM ET
    $QNRX
    Medical/Dental Instruments
    Health Care

    $AMRN
    $ARDX
    $BAND
    $BANF
    Financials

    Live finance-specific insights

    View All

    Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026

    DUBLIN and BRIDGEWATER, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular care, today announced that it will report fourth quarter and full year 2025 financial results and conduct a conference call on Wednesday, February 25, 2026. The Company will issue a press release detailing its fourth quarter and full year 2025 financial results in the pre-market hours, followed by a conference call with senior management at 8:00 a.m. ET. Information on how to participate is as follows. Access to the live call:Via telephone: Dial in within the United States: 888-506-0062International dial in: 973-528-0011Acces

    2/11/26 8:00:00 AM ET
    $AMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Stellantis Resets its Business to Meet Customer Preferences and to Support Profitable Growth

    Stellantis Resets its Business to Meet Customer Preferences and to Support Profitable Growth H2 2025 charges of approximately €22 billion primarily reflect a strategic shift to put freedom of choice – from a growing range of EVs, hybrids and advanced internal combustion engines – at the heart of the Company's plans Preliminary financial results disclosed for H2 2025; improved Net Revenues and Industrial Free Cash Flow (IFCF). Adjusted Operating Income (AOI) & Net Income impacted by specific items This reset of Stellantis' business resulted in charges of approximately €22.2 billion(1) excluded from AOI(2) for the second half of 2025, including cash payments of approximately €6.5 billion, w

    2/6/26 2:01:00 AM ET
    $STLA
    Auto Manufacturing
    Industrials

    Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026

    WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced it will hold a conference call on Thursday, February 19, 2026, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the full year and fourth quarter of 2025. The call will include commentary from members of the Ardelyx Executive Leadership Team including Mike Raab, President and Chief Executive Officer, Sue Hohenleitner, Chief Financial Officer, Eric Foster, Chief Commercial Officer, and Laura

    2/5/26 8:00:00 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care